Labeler
Camber Pharmaceuticals, Inc. NDC Codes
Camber Pharmaceuticals, Inc. lists 643 finished drug products in the FDA NDC Directory under NDC labeler code 31722.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Buprenorphine and Naloxone, Milnacipran Hydrochloride, Olmesartan medoxomil, amlodipine and hydrochlorothiazide, Eltrombopag, Topiramate, Pomalidomide, Fluphenazine Hydrochloride, mirtazapine, Afatinib, Losartan Potassium And Hydrochlorothiazide, Cisatracurium Besylate, Oxycodone Hydrochloride, spironolactone, Olmesartan medoxomil and hydrochlorothiazide, Sacubitril and valsartan
- Active ingredients
- Hydrochlorothiazide, Olmesartan medoxomil, Buprenorphine hydrochloride, Amlodipine besylate, Eltrombopag olamine, Naloxone hydrochloride, Topiramate, Milnacipran hydrochloride, Pomalidomide, Fluphenazine hydrochloride, Mirtazapine, Afatinib dimaleate
- NDC labeler codes
- 31722
- Strengths (from the 100 most recently listed products)
- Hydrochlorothiazide 12.5 mg/1; Olmesartan medoxomil 40 mg/1; Hydrochlorothiazide 25 mg/1; Buprenorphine hydrochloride 2 mg/1; Buprenorphine hydrochloride 8 mg/1; Amlodipine besylate 5 mg/1; Olmesartan medoxomil 20 mg/1; Sugammadex sodium 100 mg/mL; Losartan potassium 100 mg/1; Cisatracurium besylate 2 mg/mL; Amlodipine besylate 10 mg/1; Acetaminophen 325 mg/1; Carbidopa 25 mg/1; Levodopa 100 mg/1; Eltrombopag olamine 12.5 mg/1; Eltrombopag olamine 25 mg/1; Clomiphene citrate 50 mg/1; Glycerol phenylbutyrate 1.1 g/mL; Afatinib dimaleate 20 mg/1; Afatinib dimaleate 30 mg/1
- Dosage forms
- Tablet, Film coated, Tablet, Capsule, Capsule, Extended release, Injection, Solution, Film, Soluble, Injection, Solution, Powder, For suspension, Kit, Suspension, Tablet, Extended release, Liquid, Powder, For solution, Injection, Powder, Lyophilized, For solution, Suppository
- Routes
- Oral, Sublingual, Intravenous, Buccal, Rectal, Subcutaneous, Intramuscular
- Drug classes (FDA established)
- Angiotensin 2 Receptor Blocker, Thiazide Diuretic, Partial Opioid Agonist, Opioid Antagonist, Kinase Inhibitor, Phenothiazine, Opioid Agonist, Calcium Channel Blocker, Dihydropyridine Calcium Channel Blocker, Thrombopoietin Receptor Agonist, Serotonin and Norepinephrine Reuptake Inhibitor, Thalidomide Analog, Nondepolarizing Neuromuscular Blocker, Serotonin Reuptake Inhibitor, Aldosterone Antagonist, Neprilysin Inhibitor, Aromatic Amino Acid, Histamine-1 Receptor Antagonist, Aminoketone, Serotonin-1b and Serotonin-1d Receptor Agonist, Serotonin-4 Receptor Agonist, Chloride Channel Activator, Estrogen Agonist/Antagonist, Nitrogen Binding Agent, Amino Acid, Sigma-1 Agonist, Uncompetitive N-methyl-D-aspartate Receptor Antagonist, Central Nervous System Depressant, Aminosalicylate, Azole Antifungal, Tetracycline-class Drug, Nonsteroidal Anti-inflammatory Drug, Nitrofuran Antibacterial, Hematopoietic Stem Cell Mobilizer, Calculi Dissolution Agent, Osmotic Laxative, Retinoid, Factor Xa Inhibitor
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 184 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Eltrombopag | Eltrombopag olamine 75 mg/1 | Tablet, Film coatedOral | 31722-844 | 31722-0844-30 | — |
| Zinc Sulfate | Zinc sulfate 1 mg/mL | Injection, SolutionIntravenous | 31722-453 | 31722-0453-31 | — |
| Zinc Sulfate | Zinc sulfate 3 mg/mL | Injection, SolutionIntravenous | 31722-454 | 31722-0454-31 | — |
| Zinc Sulfate | Zinc sulfate 5 mg/mL | Injection, SolutionIntravenous | 31722-455 | 31722-0455-31 | — |
| ABACAVIR and LAMIVUDINE | Abacavir sulfate 600 mg/1; Lamivudine 300 mg/1 | Tablet, Film coatedOral | 31722-838 | 31722-0838-30 | — |
| Nitazoxanide | Nitazoxanide 500 mg/1 | Tablet, Film coatedOral | 31722-100 | 31722-0100-3031722-0100-3131722-0100-32 | — |
| Imatinib Mesylate | Imatinib mesylate 100 mg/1 | Tablet, Film coatedOral | 31722-296 | 31722-0296-90 | — |
| Imatinib Mesylate | Imatinib mesylate 400 mg/1 | Tablet, Film coatedOral | 31722-297 | 31722-0297-30 | — |
| Chlorzoxazone | Chlorzoxazone 250 mg/1 | TabletOral | 31722-974 | 31722-0974-0131722-0974-0531722-0974-10+2 more | — |
| Metformin Hydrochloride | Metformin hydrochloride 500 mg/5mL | SolutionOral | 31722-042 | 31722-0042-47 | — |
| Bumetanide | Bumetanide .25 mg/mL | InjectionIntramuscular, Intravenous | 31722-369 | 31722-0369-32 | — |
| Bumetanide | Bumetanide .25 mg/mL | InjectionIntramuscular, Intravenous | 31722-368 | 31722-0368-32 | — |
| spironolactone | Spironolactone 25 mg/5mL | SuspensionOral | 31722-691 | 31722-0691-1131722-0691-47 | — |
| Amlodipine and Olmesartan Medoxomil | Amlodipine besylate 10 mg/1; Olmesartan medoxomil 40 mg/1 | Tablet, Film coatedOral | 31722-448 | 31722-0448-3031722-0448-90 | — |
| Amlodipine and Olmesartan Medoxomil | Amlodipine besylate 5 mg/1; Olmesartan medoxomil 20 mg/1 | Tablet, Film coatedOral | 31722-445 | 31722-0445-3031722-0445-90 | — |
| Amlodipine and Olmesartan Medoxomilaamlodipine and olmesartan medoxomil | Amlodipine besylate 5 mg/1; Olmesartan medoxomil 40 mg/1 | Tablet, Film coatedOral | 31722-446 | 31722-0446-3031722-0446-90 | — |
| Amlodipine and Olmesartan Medoxomil | Amlodipine besylate 10 mg/1; Olmesartan medoxomil 20 mg/1 | Tablet, Film coatedOral | 31722-447 | 31722-0447-3031722-0447-90 | — |
| Norepinephrine bitartrate | Norepinephrine bitartrate 1 mg/mL | Injection, Solution, ConcentrateIntravenous | 31722-372 | 31722-0372-32 | — |
| Oxaliplatin | Oxaliplatin 100 mg/20mL | Injection, Solution, ConcentrateIntravenous | 31722-358 | 31722-0358-20 | — |
| Oxaliplatin | Oxaliplatin 50 mg/10mL | Injection, Solution, ConcentrateIntravenous | 31722-357 | 31722-0357-10 | — |
| Darunavir | Darunavir 800 mg/1 | Tablet, Film coatedOral | 31722-089 | 31722-0089-30 | — |
| Darunavir | Darunavir 600 mg/1 | Tablet, Film coatedOral | 31722-088 | 31722-0088-60 | — |
| Potassium chloride | Potassium chloride 20 meq/15mL | SolutionOral | 31722-494 | 31722-0494-47 | — |
| Potassium chloride | Potassium chloride 40 meq/15mL | SolutionOral | 31722-495 | 31722-0495-47 | — |
| Posaconazole | Posaconazole 18 mg/mL | SolutionIntravenous | 31722-370 | 31722-0370-31 | — |
| Raltegravir | Raltegravir potassium 400 mg/1 | Tablet, Film coatedOral | 31722-584 | 31722-0584-60 | — |
| Furosemide | Furosemide 10 mg/mL | Injection, SolutionIntravenous | 31722-309 | 31722-0309-32 | — |
| Furosemide | Furosemide 10 mg/mL | Injection, SolutionIntravenous | 31722-310 | 31722-0310-32 | — |
| Furosemide | Furosemide 10 mg/mL | Injection, SolutionIntravenous | 31722-311 | 31722-0311-31 | — |
| Chlorpromazine Hydrochloride | Chlorpromazine hydrochloride 25 mg/mL | InjectionIntramuscular | 31722-366 | 31722-0366-32 | — |
| Chlorpromazine Hydrochloride | Chlorpromazine hydrochloride 25 mg/mL | InjectionIntramuscular | 31722-367 | 31722-0367-32 | — |
| Thiamine Hydrochloride | Thiamine hydrochloride 100 mg/mL | Injection, SolutionIntramuscular, Intravenous | 31722-363 | 31722-0363-32 | — |
| Mycophenolate Mofetil | Mycophenolate mofetil 250 mg/1 | CapsuleOral | 31722-878 | 31722-0878-0131722-0878-05 | — |
| Mycophenolate Mofetil | Mycophenolate mofetil 500 mg/1 | Tablet, Film coatedOral | 31722-879 | 31722-0879-0131722-0879-05 | — |
| Sodium sulfate, potassium sulfate and magnesium sulfate | Sodium sulfate 17.5 g/177mL + 2 more ingredients | SolutionOral | 31722-098 | 31722-0098-31 | — |
| Azacitidine | Azacitidine 100 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous, Subcutaneous | 31722-365 | 31722-0365-31 | — |
| Sirolimus | Sirolimus 1 mg/mL | SolutionOral | 31722-316 | 31722-0316-31 | — |
| Lisdexamfetamine Dimesylate | Lisdexamfetamine dimesylate 30 mg/1 | CapsuleOral | 31722-352 | 31722-0352-01 | — |
| Lisdexamfetamine Dimesylate | Lisdexamfetamine dimesylate 10 mg/1 | CapsuleOral | 31722-350 | 31722-0350-01 | — |
| Lisdexamfetamine Dimesylate | Lisdexamfetamine dimesylate 20 mg/1 | CapsuleOral | 31722-351 | 31722-0351-01 | — |
| Lisdexamfetamine Dimesylate | Lisdexamfetamine dimesylate 40 mg/1 | CapsuleOral | 31722-353 | 31722-0353-01 | — |
| Lisdexamfetamine Dimesylate | Lisdexamfetamine dimesylate 50 mg/1 | CapsuleOral | 31722-354 | 31722-0354-01 | — |
| Lisdexamfetamine Dimesylate | Lisdexamfetamine dimesylate 60 mg/1 | CapsuleOral | 31722-355 | 31722-0355-01 | — |
| Lisdexamfetamine Dimesylate | Lisdexamfetamine dimesylate 70 mg/1 | CapsuleOral | 31722-356 | 31722-0356-01 | — |
| Dextromethorphan hydrobromide and quinidine sulfate | Dextromethorphan hydrobromide 20 mg/1; Quinidine sulfate 10 mg/1 | CapsuleOral | 31722-693 | 31722-0693-60 | — |
| Temozolomide | Temozolomide 5 mg/1 | CapsuleOral | 31722-411 | 31722-0411-1431722-0411-31 | — |
| Temozolomide | Temozolomide 180 mg/1 | CapsuleOral | 31722-415 | 31722-0415-1431722-0415-31 | — |
| Temozolomide | Temozolomide 20 mg/1 | CapsuleOral | 31722-412 | 31722-0412-1431722-0412-31 | — |
| Temozolomide | Temozolomide 100 mg/1 | CapsuleOral | 31722-413 | 31722-0413-1431722-0413-31 | — |
| Temozolomide | Temozolomide 140 mg/1 | CapsuleOral | 31722-414 | 31722-0414-1431722-0414-31 | — |
Camber Pharmaceuticals, Inc.: common questions
- What is Camber Pharmaceuticals, Inc.'s NDC labeler code?
- 31722. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Camber Pharmaceuticals, Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.